Expansion of CD14+CD16+ monocytes producing TNF-α in complication-free diabetes type 1 juvenile onset patients

Cytokine

Volumn 60, Issue 1, 2012, Pages 309-317

  Myśliwska, Jolanta ^a   Smardzewski, Marcin ^a   Marek Trzonkowska, Natalia ^a   Myśliwiec, Małgorzata ^a   Raczyńska, Krystyna ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Diabetes mellitus; Monocyte subsets; TNF

Indexed keywords

C REACTIVE PROTEIN; CD14 ANTIGEN; CD16 ANTIGEN; HLA DR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETIC RETINOPATHY; DISEASE DURATION; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOM SAMPLE;

ADOLESCENT; ANTIGENS, CD14; C-REACTIVE PROTEIN; CELL PROLIFERATION; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; FEMALE; FLOW CYTOMETRY; HLA-DR ANTIGENS; HUMANS; INFLAMMATION MEDIATORS; MALE; MONOCYTES; RECEPTORS, IGG; REGRESSION ANALYSIS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 84865415513     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.03.010     Document Type: Article

References (61)

1. Devaraj S., Glaser N., Griffen S., Wang-Polagruto J., Miguelino E., Jialal I. Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes. Diabetes 2006, 55:774-779.
2. Schram M.T., Chaturved N., Schalkwijk C.G., Fuller J.H., Stehouwer C.D. Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes the EURODIAB Prospective Complications Study. Diabetologia 2005, 48:370-378.
3. Devaraj S., Cheung A.T., Jialal I., Griffen S.C., Nguyen D., Glaser N., et al. Evidence of increased inflammation and microcirculatory abnormalities in patients with type 1 diabetes and their role in microvascular complications. Diabetes 2007, 56:2790-2796.
4. Schalkwijk C.G., Poland D.C.W., van Dijk W., Kok A., Emeis J.J., Dräger A.M., et al. Plasma concentration of C-reactive protein is increased in Type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation. Diabetologia 1999, 42:351-357.
5. Devaraj S., Dasu M.R., Rockwood J., Winter W., Griffen S.C., Jialal I. Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state. J Clin Endocrinol Metab 2008, 93:578-583.
6. Joussen A.M., Doehmen S., Le M.L., Koizumi K., Radetzky S., Krohne T.U., et al. TNF-alpha mediated apoptosis plays an important role in the development of early diabetic retinopathy and long-term histopathological alterations. Mol Vis 2009, 25:1418-1428.
7. Zorena K., Myśliwska J., Myśliwiec M., Balcerska A., Lipowski P., Raczyńska K. Interleukin-12 and tumour necrosis factor-alpha equilibrium is a prerequisite for clinical course free from late complications in children with type 1 diabetes mellitus. Scand J Immunol 2008, 67:204-208.
8. Zorena, K., Myśliwska, J., Myśliwiec, M., Balcerska, A., Hak, Ł., Lipowski, P., Raczyńska, K. Serum TNF-alpha level predicts nonproliferative diabetic retinopathy in children, Med Inflamm 2007 Article I.D.92196, doi: http://dx.doi.org/10.1155/2007/92196.
9. Renier G., Mamputu J.C., Desfaits A.C., Serri O. Monocyte adhesion in diabetic angiopathy. Effects of free radical scavenging. J Diabetes Complic 2003, 17:20-29.
10. Bai N., Tang S., Ma J., Luo Y., Lin S. Increased expression of intercellular adhesion molecule-1, vascular cellular adhesion molecule-1 and leukocyte common antigen in diabetic rat retina. Yan Ke Xue Bao 2003, 19:176-183.
11. Sanchez-Niño, M.D., Benito-Martin, A., Gonçalves, S., Sanz, A.B., Ucero, A.C., Izquierdo, M.C., Ramos, A.M., Berzal, S., Selgas, R., Ruiz-Ortega, M., Egido, J., Ortiz, A. TNF superfamily: a growing saga of kidney injury modulators, Mediators Inflamm. 2010 pii: 182958. doi: 10.1155/2010/182958.
12. Yang D., Elner S.G., Chen X., Field M.G., Petty H.R., Elner V.M. MCP-1-activated monocytes induce apoptosis in human retinal pigment epithelium. Invest Ophthalmol Vis Sci 2011, 52:6026-6034.
13. Behl Y., Krothapalli P., Desta T., DiPiazza A., Roy S., Graves D.T. Diabetes-enhanced tumor necrosis factor-α production promotes apoptosis and the loss of retinal microvascular cells in type 1 and type 2 models of diabetic retinopathy. Am J Pathol 2008, 172:1411-1418.
14. Hatanaka E., Monteaguado P.T., Marrocos M.S.M., Campa A. Neutrophils and monocytes as potentially important sources of proinflammatory cytokines in diabetes. Clin Exp Immunol 2006, 146:443-447.
15. Joussen A.M., Poulaki V., Le M.L., Koizumi K., Esser C., Janicki H., et al. Central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J 2004, 18:1450-1452.
16. Ziegler-Heitbrock L., Ancuta P., Crowe S., Dalod M., Grau V., Hart D.N., et al. Nomenclature of monocytes and dendritic cells in blood. Blood 2010, 116:74-80.
17. Geissmann F., Auffray C., Palframan R., Wirrig C., Ciocca A., Campisi L., et al. Blood monocytes: distinct subsets, how they relate to dendritic cells, and their possible roles in the regulation of T-cell responses. Immunol Cell Biol 2008, 86:398-408.
18. van de Veerdonk F.L., Netea M.G. Diversity: a hallmark of monocyte society. Immunity 2010, 33:289-291.
19. Saha P., Geissmann F. Toward a functional characterization of blood monocytes. Immunol Cell Biol 2011, 89:2-4.
20. Cros J., Cagnard N., Woollard K., Patey N., Zhang S.Y., Senechal B., et al. Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity 2010, 33:375-386.
21. + dendritic cells evoking Th1 and Th17 responses. J Immunol 2007, 179:1449-1457.
22. Bradshaw E.M., Raddassi K., Elyaman W., Orban T., Gottlieb P.A., Kent S.C., et al. Monocytes from patients with type 1 diabetes spontaneously secrete proinflammatory cytokines inducing Th17 cells. J Immunol 2009, 183:4432-4439.
23. Csorba T.R., Lyon A.W., Hollenberg M.D. Autoimmunity and the pathogenesis of type 1 diabetes. Crit Rev Clin Lab Sci 2010, 47:51-71.
24. Waltenberger J. VEGF resistance as a molecular basis to explain the angiogenesis paradox in diabetes mellitus. Biochem Soc Trans 2009, 37:1167-1170.
25. Praidou A., Androudi S., Brazitikos P., Karakiulakis G., Papakonstantinou E., Dimitrakos S. Angiogenic growth factors and their inhibitors in diabetic retinopathy. Curr Diabetes Rev 2010, 6:304-312.
26. Lenz T., Haak T., Malek J., Gröne H.J., Geiger H., Gossmann J. Vascular endothelial growth factor in diabetic nephropathy. Kidney Blood Press Res 2003, 26:338-343.
27. American Diabetes Association. Diabetes Care 2008, 31(Suppl. 1):S55-S60. Diagnosis and classification of diabetes mellitus.
28. Early Treatment Diabetic Retinopathy Study Research Group 1991Classification of diabetic retinopathy from fluorescein angiograms: ETDRS report nr 11, Ophtalmology 98 (1991) suppl. 5: 807-822.
29. Alles V.V., Bottazzi B., Peri G., Golay J., Introna M., Mantovani A. Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes. Blood 1994, 84:3483-3493.
30. Lim L.S., Tai E.S., Mitchell P., Wang J.J., Tay W.T., Lamoureux E., et al. C-reactive protein, body mass index, and diabetic retinopathy. Invest Ophthalmol Vis Sci 2010, 51:4458-4463.
31. Frankenberger M., Sternsdorf T., Pechumer H., Pforte A., Loms Ziegler-Heitbrock H.W. Differential cytokine expression in human blood monocyte subpopulation: a polymerase chain reaction analysis. Blood 1996, 87:373-377.
32. ++ monocytes are a major source of TNF. J Immunol 2002, 168:3536-3542.
33. + monocytes in response to sepsis-related antigens. Clin Exp Immunol 2005, 141:270-278.
34. + monocytes produce IL-6, CCL2, and matrix metalloproteinase-9 upon interaction with CX3CL1-expressing endothelial cells. J Leukoc Biol 2006, 80:1156-1164.
35. Bergtold A., Gavhane A., D'Agati V., Madaio M., Clynes R. FcR-bearing myeloid cells are responsible for triggering murine lupus nephritis. J Immunol 2006, 177:7287-7295.
36. + monocytes in glomeruli of active lupus nephritis. Am J Kidney Dis 2007, 50:47-58.
37. Randolph G.J., Sanchez-Schmitz G., Liebman R.M., Schäkel K. The CD16(+) (FcgammaRIII(+)) subset of human monocytes preferentially becomes migratory dendritic cells in a model tissue setting. J Exp Med 2002, 196:517-527.
38. Schraufstatter, I.U., Zhao, M., Khaldoyanidi, S.K., Discipio, R.G. The chemokine CCL18 causes maturation of cultured monocytes to macrophages in the M2 spectrum, Immunology 2011 doi: 10.1111/j.1365-2567.2011.03541.x. [Epub ahead of print].
39. Bertin-Maghit S., Pang D., O'Sullivan B., Best S., Duggan E., Paul S., et al. Interleukin-1β produced in response to islet autoantigen presentation differentiates T-helper 17 cells at the expense of regulatory T-cells: Implications for the timing of tolerizing immunotherapy. Diabetes 2011, 60:248-257.
40. Auffray C., Fogg D., Garfa M., Elain G., Join-Lambert O., Kayal S., et al. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 2007, 31:666-670.
41. Gratchev A., Kzhyshkowska J., Köthe K., Muller-Molinet I., Kannookadan S., Utikal J., et al. Mphi1 and Mphi2 can be re-polarized by Th2 or Th1 cytokines, respectively, and respond to exogenous danger signals. Immunobiology 2006, 211:473-486.
42. Antonelli A., Fallahi P., Ferrari S.M., Pupilli C., d'Annunzio G., Lorini R., et al. Serum Th1 (CXCL10) and Th2 (CCL2) chemokine levels in children with newly diagnosed Type 1 diabetes: a longitudinal study. Diabet Med 2008, 25:1349-1353.
43. Chatzigeorgiou A., Harokopos V., Mylona-Karagianni C., Tsouvalas E., Aidinis V., Kamper E.F. The pattern of inflammatory/anti-inflammatory cytokines and chemokines in type 1 diabetic patients over time. Ann Med 2010, 42:426-438.
44. Devaraj S., Jialal L. C-reactive protein polarizes human macrophages to an M1 phenotype and inhibits transformation to the M2 phenotype. Atheroscler Thromb Vasc Biol 2011, 31:1397-1402.
45. Myśliwska J., Zorena K., Semetkowska-Jurkiewicz E., Rachoń D., Suchanek H., Myśliwski A. High levels of circulating interleukin-10 in diabetic nephropathy patients. Eur Cytokine Netw 2005, 16:117-122.
46. Sánchez-Torres C., García-Romo G.S., Cornejo-Cortés M.A., Rivas-Carvalho A., Sánchez-Schmitz G. CD16+ and CD16- human blood monocyte subsets differentiate in vitro to dendritic cells with different abilities to stimulate CD4+ T cells. Int Immunol 2001, 13:1571-1581.
47. Nikolic T., Bouma G., Drexhage H.A., Leenen P.J. Diabetes-prone NOD mice show an expanded subpopulation of mature circulating monocytes, which preferentially develop into macrophage-like cells in vitro. J Leukocyte Biol 2005, 78:70-79.
48. Classen A., Lloberas J., Celada A. Macrophage activation: classical versus alternative. Methods Mol Biol 2009, 531:29-43.
49. Macaubas, C., Nguyen, D.K., Peck, A., Buckingham, J., Deshpande, Ch., Wong, E., Alexander, H.C., Chang, S.Y., Begovich, A., Sun, Y., Park, J.L., Pan, K.H., Lin, R., Lih, Ch.J., Augustine, E.M., Phillips, C., Hadjinicolaou, A.V., Lee, T. Mellins, E.D. Alternative activation in systemic juvenile idiopathic arthritis monocytes, Clinical Immunology 20212 in press.
50. Honorati M.C., Cattini L., Facchini A. VEGF production by osteoarthritic chondrocytes cultured in micromass and stimulated by IL-17 and TNF-alpha. Connect Tissue Res 2007, 48:239-245.
51. Asano-Kato N., Fukagawa K., Okada N., Kawakita T., Takano Y., Dogru M., et al. TGF-beta1, IL-1beta, and Th2 cytokines stimulate vascular endothelial growth factor production from conjunctival fibroblasts. Exp Eye Res 2005, 80:555-560.
52. Nevala W.K., Vachon C.M., Leontovich A.A., Scott C.G., Thompson M.A., Markovic S.N. Melanoma Study Group of the Mayo Clinic Cancer Center. Evidence of systemic Th2-driven chronic inflammation in patients with metastatic melanoma. Clin Cancer Res 2009, 15:1931-1939.
53. Ishida S., Usui T., Yamashiro K., Kaji Y., Ahmed E., Carrasquillo K.G., et al. VEGF164 is proinflammatory in the diabetic retina. Invest Ophthalmol Vis Sci 2003, 44:2155-2162.
54. Wang J.L., Qian X., Chinookoswong N., Lu J., Chow G., Theill L.E., et al. Polyethylene glycolated recombinant TNF receptor I improves insulitis and reduces incidence of spontaneous and cyclophosphamide-accelerated diabetes in non-obese diabetic mice. Endocrinology 2002, 143:3490-3497.
55. Joussen A.M., Poulaki V., Mitsiades N., Kirchhof B., Koizumi K., Dohmen S., et al. Non-steroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-α suppression. FASEB J 2002, 16:438-440.
56. Yazdani-Biuki B., Stelzl H., Brezinschek H.P., Hermann J., Mueller T., Krippl P., et al. Improvement of insulin sensitivity in insulin resistant subjects during prolonged treatment with the anti-TNF-α antibody infliximab. Eur J Clin Invest 2004, 34:641-642.
57. Sasakawa T., Sasakawa Y., Masunaga T., Fujitsu T., Hirayama Y., Ohkubo Y., et al. FK506 suppresses E-selectin, ICAM-1 and VCAM-1 expression on vascular endothelial cells by inhibiting tumor necrosis factor alpha secretion from peripheral blood mononuclear cells. Cytokine 2005, 29:67-71.
58. Migliore A., Massafra U., Carloni E., Padalino C., Martin S., Lasaracina F., et al. TNF-alpha blockade induce clinical remission in patients affected by polymyalgia rheumatica associated to diabetes mellitus and/or osteoporosis: a seven cases report. Eur Rev Med Pharmacol Sci 2005, 6:373-378.
59. Gonzalez-Gay M.A., De Matias J.M., Gonzalez-Juanatey C., Garcia-Porrua C., Sanchez-Andrade A. Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis. Clin Exp Rheumatol 2006, 24:83-86.
60. Sfikakis P.P., Markomichelakis N., Theodossiadis G.P., Grigoropoulos V., Katsilambros N., Theodossiadis P.G. Regression of sight-threatening macular edema in type 2 diabetes following treatment with the anti-tumor necrosis factor monoclonal antibody infliximab. Diabetes Care 2005, 28:445-447.
61. Rutella S., Fiorino G., Vetrano S., Correale C., Spinelli A., Pagano N., et al. Infliximab therapy inhibits inflammation-induced angiogenesis in the mucosa of patients with Crohn's disease. Am J Gastroenterol 2011, 106:762-770.